How to choose the right sodium hyaluronate raw material for supplements, medical devices, and injectable products
Sodium hyaluronate is not simply a matter of choosing the “higher” grade. What really matters is whether the raw material is suitable for your product application, whether the supplier can provide quality documents matched to that application, and whether those documents can support your formulation, manufacturing, and regulatory work.
1. First, identify your product application
An oral product first needs to address whether it can be used safely and consistently in a nutritional product; an injectable product must also support development within a more stringent quality and manufacturing process.
If you are developing capsules, tablets, powders, or functional beverages, you will generally first consider sodium hyaluronate intended for food and dietary supplement applications. In this case, solubility, molecular weight, powder handling, microbiological quality, heavy metals, batch consistency, and food-related documentation are often more important than the “injectable grade” or “pharmaceutical grade” label.
If you are developing intra-articular injections, dermal fillers, ophthalmic products, or other parenteral products, the priorities change. You need to further confirm endotoxins, protein, nucleic acids, residual solvents, solution clarity, microbiological quality, filtration or sterile-processing requirements, and the stability and safety validation of the finished product.
2. What are the main differences between oral and injectable grades?
| Comparison item | Oral/Food applications | Injectable product development |
|---|---|---|
| Typical products | Dietary supplements, capsules, tablets, powders, and functional beverages | Intra-articular injections, dermal fillers, ophthalmic products, or other parenteral product development |
| Primary concerns | Food-use suitability, solubility, molecular weight, microbiological quality, heavy metals, and batch consistency | Endotoxins, protein and nucleic-acid residues, solution clarity, microbiological quality, filtration/sterile-processing strategy, and finished-product validation |
| Assay listed on the food-grade page | The page header shows Assay ≥90%; the full specification table lists sodium hyaluronate content ≥87.0% | — |
| Assay listed on the injectable-grade page | — | 95.0%–105.0% |
| Endotoxins | No specific limit is listed in the complete food-grade specification table | <0.05 IU/mg |
| Protein | ≤0.1% | Actual ≤0.05% |
| Solution performance | Transmittance T600nm ≥99.0% | Clear solution; A600nm ≤0.01 |
| Molecular-weight options | Low: 10,000–400,000 Da; medium: 400,000–1,000,000 Da; high: 1,000,000–1,800,000 Da | Low: 10,000–400,000 Da; medium: 400,000–1,500,000 Da; high: 1,500,000–2,200,000 Da |
| Listed shelf life | 36 months | 24 months |
Note: The figures in the table above come from the corresponding JointSourceBio product COA data. For actual purchasing, the applicable batch TDS, COA, test methods, and quality standards agreed by both parties should be used as the basis.
3. Why can’t food-grade material be directly substituted for injectable grade?
Both materials may be called “sodium hyaluronate,” but they serve products with different risk profiles. Dietary supplements are administered orally, so the raw material is evaluated primarily for food-use suitability, contaminant control, and batch consistency. Injectable products bypass the body’s digestive barrier and therefore place greater demands on pyrogens, microorganisms, impurities, particles, and the manufacturing process.
Therefore, if you already have a food-grade raw material, you should not use it directly in injectable product development simply because its assay or molecular weight appears similar. Changing the grade may affect:
- Endotoxin and microbiological control procedures;
- Quality standards for protein, nucleic acids, and residual solvents;
- Solution clarity, particulate control, and filtration processes;
- Finished-product stability, packaging, and release testing.
The correct approach is to define the final application first, then ask the supplier for product information and samples suitable for that application, followed by validation by your R&D, quality, and regulatory teams.
4. How should you choose the molecular weight?
Molecular weight affects the viscosity, flow behavior, dissolution performance, and final formulation characteristics of sodium hyaluronate solutions. Molecular weight alone does not determine product quality; it needs to be considered together with the dosage form, concentration, target viscosity, and manufacturing equipment.
For oral supplements
Low- to medium-molecular-weight grades are generally easier to formulate in functional beverages, powders, and everyday nutritional products. Capsules and tablets also require consideration of particle size, blend uniformity, and the tableting or filling process. The JointSourceBio food-grade page lists low-, medium-, and high-molecular-weight ranges, which customers can further match to their dosage form and target viscosity.
For injectable product development
Molecular weight must be validated together with concentration, intrinsic viscosity, injection device, filtration approach, and the rheological performance of the finished product. The JointSourceBio injectable-grade page lists low-, medium-, and high-molecular-weight ranges, but this does not mean that every range is suitable for every injectable product. When requesting a quotation, specify the final application, target viscosity, or formulation concentration.
5. What should you confirm when purchasing oral-grade sodium hyaluronate?
For supplement brands and food formulation teams, we recommend confirming the following during the inquiry stage:
- Is the raw material suitable for your target market and finished-product category?
- Are the molecular weight, intrinsic viscosity, and particle size suitable for your dosage form?
- Can the supplier provide a batch COA, TDS, and SDS?
- Does the COA include assay, glucuronic acid, pH, moisture, ash, heavy metals, and microbiological items?
- Do you need a non-GMO statement, Halal certification, or other market-specific documents?
- Do the sample and commercial batch have the same specifications?
- What are the packaging, storage, and opened-package handling requirements?
The JointSourceBio food-grade sodium hyaluronate COA shows that the product is fermentation-derived and lists assay, glucuronic acid, pH, moisture, ash, heavy metals, and microbiological items. TDS and MSDS documents can also be requested. Specific documents can be sent by contacting us.
6. What should you confirm when purchasing injectable-grade sodium hyaluronate?
Injectable product development generally requires more comprehensive technical information. We recommend asking the supplier the following questions:
- Which application is the injectable-grade specification intended for: intra-articular, ophthalmic, aesthetic, or another medical product?
- What is the endotoxin limit? What are the test method, unit, and batch-testing frequency?
- Are test results available for protein, nucleic acids, residual solvents, heavy metals, and microbiological quality?
- How are molecular weight and intrinsic viscosity tested? Can the supplier provide a distribution profile or representative batch data?
- How should solution clarity, filter compatibility, and particulate control be validated?
- What specific evidence can be provided for the pharmacopeial compliance and quality-system documents stated on the product page?
- In what form is the raw material delivered? Does “injectable grade” mean that the raw material itself is sterile?
- Can the supplier provide samples, batch COAs, TDS, endotoxin reports, and stability data?
The JointSourceBio injectable-grade sodium hyaluronate COA shows the following items: assay 95.0%–105.0%, endotoxins <0.05 IU/mg, protein ≤0.1%, nucleic acids A260nm ≤0.05, and solution clarity A600nm ≤0.01. TDS, COAs, and the corresponding test reports can also be provided.
7. Raw-material compliance and finished-product compliance are not the same thing
This is one of the most easily misunderstood points in injectable product development. If a sodium hyaluronate raw material meets a specified standard, it means only that it meets the applicable requirements for the quality attributes defined by the supplier. The finished product still requires its own development and validation based on the product type and target market.
| Stage | What needs to be confirmed |
|---|---|
| Raw material | Assay, molecular weight, intrinsic viscosity, protein, nucleic acids, residual solvents, heavy metals, microbiological quality, endotoxins, and storage conditions |
| Formulation and process | Dissolution time, temperature, shear, pH, buffer system, filter compatibility, container compatibility, and particulate control |
| Finished product | Sterility or sterility assurance, bacterial endotoxins, visible and subvisible particles, stability, container-closure integrity, and biocompatibility |
| Target market | Based on product classification in the United States, European Union, China, or another market, confirm the applicable drug, medical-device, or other submission and quality requirements |
Therefore, “injectable grade” does not mean that the finished injectable product has already obtained FDA, CE, NMPA, or other market approval; “sterile-filterable” does not mean that the customer can skip validation of the final process. We need to confirm these boundaries with you together.
8. Four frequently asked questions
Can oral-grade sodium hyaluronate be used directly for injectable product development?
Direct substitution is not recommended. Endotoxins, protein, nucleic acids, microbiological quality, solution clarity, particles, filtration, and finished-product validation requirements should be reconfirmed.
Does injectable grade necessarily mean that the raw material itself is sterile?
This cannot be determined from the product name alone. You need to review the specific batch documents, packaging status, microbiological and endotoxin data, and confirm your own sterile-processing or filling validation.
Does a higher molecular weight mean a better product?
Not necessarily. Molecular weight should be matched to the dosage form, concentration, target viscosity, dissolution performance, and manufacturing equipment. A higher molecular weight may provide higher viscosity, but it may also make dissolution and filtration more difficult.
What information should be provided when requesting a quotation?
We recommend providing the final application, target market, dosage form, target molecular weight or viscosity, expected sample quantity, annual volume, and a list of required documents such as COA, TDS, SDS, endotoxin reports, or other supporting files.
9. How to submit an effective supplier inquiry
A clear inquiry generally makes it easier to receive an accurate response than simply asking for a quotation for sodium hyaluronate. You can prepare the information in the following format:
- Application: dietary supplement, functional beverage, intra-articular injection, aesthetic product, ophthalmic product, or another use;
- Target market: the United States, the European Union, China, or another region;
- Dosage form: capsule, tablet, powder, liquid, gel, or another form;
- Technical targets: molecular weight, intrinsic viscosity, concentration, solubility, or endotoxin requirements;
- Purchasing stage: laboratory sample, pilot production, first commercial order, or long-term supply;
- Document requirements: COA, TDS, SDS, molecular-weight report, heavy-metal report, microbiological report, endotoxin report, stability data, or certification documents.
The more complete the information, the more accurately we can recommend a grade that matches your project and reduce rework caused by an unsuitable grade, incomplete documentation, or inconsistencies between the sample and commercial batch.
10. Conclusion: choose an evidence package that fits your project
Oral sodium hyaluronate and injectable-grade sodium hyaluronate are not simply higher and lower grades. Oral products focus more on food-use suitability, dissolution performance, molecular weight, microbiological quality, heavy metals, and batch consistency. Injectable products require further confirmation of endotoxins, protein and nucleic-acid residues, solution clarity, microbiological quality, process compatibility, and finished-product validation.
When selecting a sodium hyaluronate supplier, we recommend comparing more than price or assay. Compare whether the supplier can provide clear specifications, samples, COAs, TDS, test reports, and technical support for your application. JointSourceBio provides fermentation-derived sodium hyaluronate in multiple molecular-weight ranges and grades, and can further match a suitable raw-material solution to your final application, target market, and technical requirements.
To request samples, technical documents, or a quotation, please include your application, target market, dosage form, molecular-weight/viscosity requirements, and expected purchase volume in your inquiry.